Mylan Graham is from New Haven High School just outside of Fort Wayne — so no, this isn’t the South Bend kid, but it’s all ...

July 29 (Reuters) - Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV, a move that leaves Pfizer with its more profitable ...

Mylan is recalling more than 4 million bottles of its cholesterol-lowering atorvastatin in all dosage forms over the possibility that some pills may be contaminated. Generic makers earn their livings ...

Mylan NV finalized a $465 million settlement with the U.S. Justice Department. The settlement resolves claims the pharmaceutical company overcharged the government for its EpiPen emergency allergy ...

Mylan CEO Heather Bresch survived an ouster attempt by angry shareholders. Heather Bresch is willing to participate in a high-profile industry conference this week, but not testify before Congress — ...

Mylan is settling with the Securities and Exchange Commission for $30 million on charges it didn't disclose an EpiPen settlement loss in a timely manner. (Mylan) Mylan’s long-running EpiPen scandal ...

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...

Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...

The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...

A former Mylan information technology executive pleaded guilty to an insider trading scheme in which he acted on tips from another executive ahead of public announcements about earnings, drug ...

Some pharmaceutical companies are troubled by stratospheric drug prices. Several have vowed to limit price hikes, for instance. And the powerful drug lobbying group PhRMA is at least trying to ...